rs121918738

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PS4PP3_ModeratePM5_Supporting

This summary comes from the ClinGen Evidence Repository: The NM_001165963.4(SCN1A):c.3629C>T is a missense variant predicted to cause substitution of threonine by methionine at amino acid 1210 (p.Thr1210Met). The variant has been identified in two probands with consistent phenotypes (Genetic epilepsy with febrile seizures plus) in published literature (PMID:35074891 and PMID:28202706)(PS4). One proband inherited the variant from an unaffected father (PMID:28202706). Another missense variant at the same amino acid position in SCN1A (c.3629C>A, p.Thr1210Lys) has been classified as likely pathogenic for a consistent phenotype (Dravet syndrome)(PM5_supporting). The allele frequency for the variant is 0.002% with 4 alleles in gnomAD V2.1.1 (PM2_supporting and BS1 are not met). The computational predictor REVEL gives a score of 0.841, which is above the threshold of 0.773, evidence that correlates with a maximum strength of PP3_Moderate. In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant Genetic epilepsy with febrile seizures plus on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP: PS4, PM5_supporting, PP3_Moderate. (version 1.0; March 26, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA1942910/MONDO:0018214/067

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

SCN1A
NM_001165963.4 missense

Scores

13
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1

Conservation

PhyloP100: 9.99
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PS4
For more information check the summary or visit ClinGen Evidence Repository.
PM5
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1ANM_001165963.4 linkc.3629C>T p.Thr1210Met missense_variant Exon 21 of 29 ENST00000674923.1 NP_001159435.1 P35498-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1AENST00000674923.1 linkc.3629C>T p.Thr1210Met missense_variant Exon 21 of 29 NM_001165963.4 ENSP00000501589.1 P35498-1
SCN1AENST00000303395.9 linkc.3629C>T p.Thr1210Met missense_variant Exon 20 of 28 5 ENSP00000303540.4 P35498-1
SCN1AENST00000375405.7 linkc.3596C>T p.Thr1199Met missense_variant Exon 18 of 26 5 ENSP00000364554.3 P35498-2
SCN1AENST00000409050.1 linkc.3545C>T p.Thr1182Met missense_variant Exon 18 of 26 5 ENSP00000386312.1 P35498-3

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151610
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000159
AC:
4
AN:
250842
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135546
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000548
AC:
8
AN:
1460526
Hom.:
0
Cov.:
31
AF XY:
0.00000551
AC XY:
4
AN XY:
726580
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000360
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151610
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74038
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000283
Hom.:
0
Bravo
AF:
0.00000756
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1210 of the SCN1A protein (p.Thr1210Met). This variant is present in population databases (rs121918738, gnomAD 0.01%). This missense change has been observed in individuals with clinical features of SCN1A-related conditions (PMID: 28202706; internal data). ClinVar contains an entry for this variant (Variation ID: 658067). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. This variant disrupts the p.Thr1210 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been observed in individuals with SCN1A-related conditions (PMID: 19350499), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Inborn genetic diseases Uncertain:1
Jun 23, 2020
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.T1210M variant (also known as c.3629C>T), located in coding exon 18 of the SCN1A gene, results from a C to T substitution at nucleotide position 3629. The threonine at codon 1210 is replaced by methionine, an amino acid with similar properties. This alteration was detected in an individual with febrile seizures as well as in her unaffected father (Cetica V et al. Neurology, 2017 Mar;88:1037-1044). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.86
.;.;.;D;.;.;D;.;.;.
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D;D;D;D;.;D;.;.;D;D
M_CAP
Pathogenic
0.71
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
4.3
.;.;.;H;.;.;H;.;.;.
PrimateAI
Pathogenic
0.81
D
PROVEAN
Pathogenic
-5.7
.;.;.;D;.;.;D;.;D;D
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
.;.;.;D;.;.;D;.;D;D
Sift4G
Uncertain
0.024
.;.;.;D;.;.;D;.;D;D
Polyphen
1.0
.;.;.;D;D;.;D;D;D;.
Vest4
0.84, 0.85, 0.85, 0.85
MVP
0.98
MPC
1.8
ClinPred
1.0
D
GERP RS
5.4
Varity_R
0.88
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121918738; hg19: chr2-166870330; COSMIC: COSV57675473; COSMIC: COSV57675473; API